Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib

Korean Journal of Radiology

Volumn 5, Issue 3, 2004, Pages 157-163

  Kim, Hyo Cheol ^a,b   Lee, Jeong Min ^a,b   Choi, Seung Hong ^a,b   Han, Heon ^c   Kim, Sam Soo ^c   Lee, Sang Hyun ^d   Han, Joon Koo ^a,b   Choi, Byung Ihn ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Kangwon National University   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

Abdomen, CT; Gastrointestinal stromal tumor; Neoplasms, metastases

Indexed keywords

IMATINIB; IOPROMIDE;

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; ASCITES; CANCER SIZE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LIVER METASTASIS; MALE;

EID: 7244221429     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2004.5.3.157     Document Type: Article

References (14)

1. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. RadioGraphics 2003;23:283-304
2. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580
3. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480
4. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 2003;226:527-532
5. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Anorectal gastrointestinal stromal tumors: CT and MR imaging features with clinical and pathologic correlation. AJR Am J Roentgenol 2003;180:1607-1612
6. Nishida T, Kumano S, Sugiura T, et al. Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors. AJR Am J Roentgenol 2003;180:185-189
7. Kim H-C, Lee JM, Kim SH, et al. Primary gastrointestinal stromal tumors in the omentum and mesentery: CT findings and pathologic correlations. AJR Am J Roentgenol 2004;182:1463-1467
8. Kim H-C, Lee JM, Son KR, et al. Gastrointestinal stromal tumors of the duodenum: CT and barium study findings. AJR Am J Roentgenol 2004;183:415-419
9. Megibow AJ, Balthazar EJ, Hulnick DH, Naidich DP, Bosniak MA. CT evaluation of gastrointestinal leiomyomas and leiomyosarcomas. AJR Am J Roentgenol 1985;144:727-731
10. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-1056
11. Chen MY, Bechtold RE, Savage PD. Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate). AJR Am J Roentgenol 2002;179:1059-1062
12. Bechtold RE, Chen MY, Stanton CA, Savage PD, Levine EA. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec. Abdom Imaging 2003;28:808-814
13. Bumming P, Andersson J, Meis-Kindblom JM, et al. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 2003;89:460-464
14. Gayed I, Vu T, Iyer R, et al. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent